Search results for: 'drug point'

Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) comprise innovation insights across antibody and cellular therapies. The study also encompasses recent innovations in liquid biopsy tests, drug delivery and drug discovery platforms.The Life Science, Health & Wellness TOE will feature disruptive technology advan...

This research service covers the U.S. injectable drug pipeline in 2009. Included are technology trends, Phase III pipeline analysis, selected Phase II and I pipeline analysis. The market is segmented by injectable drug delivery route: subcutaneous injectables, intravenous injectables, intramuscular injectables, and others. Major market challenges,...

This research service explores the market for drug delivery used for the treatment of ocular diseases in the Unites States of America. It analyzes the various challenges faced by pharmaceutical, biotech, and drug delivery companies, and the competitive advantages and disadvantages of their products in the market.

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

This research service analyzes the market for point-of-care testing within the United States. The market is divided into 13 segments and covers testing performed by healthcare professionals in the physician office lab, hospital, clinics, and patient self-testing environments. Each segment covers the market overview, competitive structure, market s...

The US is witnessing some major trade policy shifts that are having a significant impact on the US and the global economy. The results of the upcoming 2020 Presidential elections and policies thereafter also stand to significantly influence the growth trajectory of the US economy. In the light of these anticipated events, research on this topic has...

17 Mar 2015  |  Global  |  Market Research

Analysis of the Global Diabetes Drug Delivery Market

Future Options for End Users

Infographics

×

The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...

As the industry continues its innovation spree across novel small and large molecule therapies, such as RNA targeted small molecules, cell and gene therapies (CGT), and mRNA therapies, it is imperative for pharma sponsors to pursue partnerships to gain technology access, database generation and analysis, and pre-clinical and clinical research. Furt...